FAP and neoplasm: Radiotracers based on FAP-2286 have been evaluated at preclinical and clinical levels demonstrating selectivity towards FAP, high tumor uptake, high tumor retention, potential anti-tumor activity, and acceptable toxicity [40,41,42].